← Leaderboards
Shenghan Lai
University Of Miami Coral Gables
$32,566,126
Attributed
$32,566,126
Total exposure
11
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $2.3M · FY2005–24$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$32,566,126 · 11
By mechanism
R01$18,444,270 · 5
U01$12,663,255 · 1
R21$789,512 · 2
P01$644,522 · 1
M01$24,567 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Hiv Infections”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,259,079
- Lawrence Corey · Fred Hutchinson Cancer Center$728,701,834
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$467,263,656
- Judith S. Currier · University Of California Los Angeles$466,447,923
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
Research focus
Hiv InfectionsCocaineAtherosclerosisCardiovascular SystemAfrican AmericanAntiretroviral TherapyCoronaryCoronary ArteriosclerosisCocaine UseBaltimoreLongitudinal StudiesHeart DiseasesParticipantCocaine UsersInvestigationProtease InhibitorPharmaceutical PreparationsRisk FactorsCoronary StenosisLeadIncidenceCohortGrantCardiac
Grant awards (58)
Effects of HIV, Cocaine, and Prolonged ART Use on Subclinical Cardiovascular Disease$1,374,319
U01 · FY2024 · DA · contact PI
Cocaine Abstinence or Reduced Use May Retard Alterations in Brain Structure and Function, and Associated Cognitive Changes among African American Cocaine Users with HIV$939,459
R01 · FY2024 · DA · contact PI
Effects of HIV, Cocaine, and Prolonged ART Use on Subclinical Cardiovascular Disease$1,374,319
U01 · FY2023 · DA · contact PI
Effects of HIV, Cocaine, and Prolonged ART Use on Subclinical Cardiovascular Disease$1,374,319
U01 · FY2022 · DA · contact PI
Effects of HIV, Cocaine, and Prolonged ART Use on Subclinical Cardiovascular Disease$1,621,307
U01 · FY2021 · DA · contact PI
Effects of HIV, Cocaine, and Prolonged ART Use on Subclinical Cardiovascular Disease$1,624,176
U01 · FY2020 · DA · contact PI
The Impact of Cocaine Abstinence or Reduced Use on Radiomic Features of Noncalcified Coronary Plaques in HIV-Infected Cocaine Users with Silent Coronary Artery Disease$231,750
R21 · FY2020 · DA · contact PI
Effects of HIV, Cocaine, and Prolonged ART Use on Subclinical Cardiovascular Disease$1,771,410
U01 · FY2019 · DA · contact PI
The Impact of Cocaine Abstinence or Reduced Use on Radiomic Features of Noncalcified Coronary Plaques in HIV-Infected Cocaine Users with Silent Coronary Artery Disease$204,688
R21 · FY2019 · DA · contact PI
Effects of HIV, Cocaine, and Prolonged ART Use on Subclinical Cardiovascular Disease$1,602,891
U01 · FY2018 · DA · contact PI
Effects of HIV, Cocaine, and Prolonged ART Use on Subclinical Cardiovascular Disease$548,807
U01 · FY2017 · DA · contact PI
Effects of HIV, Cocaine, and Prolonged ART Use on Subclinical Cardiovascular Disease$1,371,707
U01 · FY2016 · DA · contact PI
Changes in Coronary Noncalcified Volume in Relation to Changes in Cocaine Use$684,265
R01 · FY2015 · DA · contact PI
Changes in Coronary Noncalcified Volume in Relation to Changes in Cocaine Use$699,461
R01 · FY2014 · DA · contact PI
Subclinical Atherosclerosis in HIV plus Black Cocaine Users$640,671
R01 · FY2014 · DA · contact PI
Changes in Coronary Noncalcified Volume in Relation to Changes in Cocaine Use$707,105
R01 · FY2013 · DA · contact PI
Subclinical Atherosclerosis in HIV plus Black Cocaine Users$631,783
R01 · FY2013 · DA · contact PI
HIV Infection, Cocaine Use and Coronary Artery Disease in HIV+ African Americans$722,940
R01 · FY2012 · DA · contact PI
Subclinical Atherosclerosis in HIV plus Black Cocaine Users$671,860
R01 · FY2012 · DA · contact PI
Subclinical Atherosclerosis in HIV plus Black Cocaine Users$142,160
R01 · FY2012 · DA · contact PI
HIV Infection, Cocaine Use and Coronary Artery Disease in HIV+ African Americans$738,957
R01 · FY2011 · DA · contact PI
Subclinical Atherosclerosis in HIV plus Black Cocaine Users$681,649
R01 · FY2011 · DA · contact PI
HIV Infection, Cocaine Use and Coronary Artery Disease in HIV+ African Americans$124,450
R01 · FY2011 · DA · contact PI
HIV Infection, Cocaine Use and Coronary Artery Disease in HIV+ African Americans$750,934
R01 · FY2010 · DA · contact PI
Subclinical Atherosclerosis in HIV plus Black Cocaine Users$704,880
R01 · FY2010 · DA · contact PI
Subclinical Atherosclerosis in HIV plus Black Cocaine Users$24,600
R01 · FY2010 · DA · contact PI
HIV Infection, Cocaine Use and Coronary Artery Disease in HIV+ African Americans$757,014
R01 · FY2009 · DA · contact PI
Subclinical Atherosclerosis in HIV plus Black Cocaine Users$522,989
R01 · FY2009 · DA · contact PI
Subclinical Atherosclerosis in HIV plus Black Cocaine Users$24,600
R01 · FY2009 · DA · contact PI
HIV Infection, Cocaine Use and Coronary Artery Disease in HIV+ African Americans$742,699
R01 · FY2008 · DA · contact PI
Subclinical Atherosclerosis in HIV plus Black Cocaine Users$638,762
R01 · FY2008 · DA · contact PI
Subclinical Atherosclerosis in HIV plus Black Cocaine Users$98,060
R01 · FY2008 · DA · contact PI
Subclinical Atherosclerosis in HIV plus Black Cocaine Users$557,669
R01 · FY2007 · DA · contact PI
CORRELATES OF DRUG USE AND HEART DISEASE$18,732
M01 · FY2007 · RR · contact PI
HIV, COCAINE, AND REGIONAL LV DYSFUNCTION$5,835
M01 · FY2007 · RR · contact PI
HIV, Cocaine & Regional Left Ventricular Dysfunction$709,216
R01 · FY2006 · DA · contact PI
Subclinical Atherosclerosis in HIV plus Black Cocaine Users$560,734
R01 · FY2006 · DA · contact PI
China MACS: An Exploratory Study$151,957
R21 · FY2006 · DA · contact PI
HIV, Cocaine & Regional Left Ventricular Dysfunction$64,255
R01 · FY2006 · DA · contact PI
HIV, Cocaine &Regional Left Ventricular Dysfunction$797,962
R01 · FY2005 · DA
Subclinical Atherosclerosis in HIV plus Black Cocaine Users$568,232
R01 · FY2005 · DA
China MACS: An Exploratory Study$201,117
R21 · FY2005 · DA
HIV, Cocaine &Regional Left Ventricular Dysfunction$615,593
R01 · FY2004 · DA
HIV, Cocaine &Regional Left Ventricular Dysfunction$105,149
R01 · FY2004 · DA
HIV, Cocaine &Regional Left Ventricular Dysfunction$80,475
R01 · FY2004 · DA
HIV, Cocaine &Regional Left Ventricular Dysfunction$537,267
R01 · FY2003 · DA
SUBCLINICAL ATHEROSCLEROSIS IN HIV+ BLACK COCAINE USERS$108,225
R01 · FY2003 · DA
HIV, Cocaine &Regional Left Ventricular Dysfunction$101,043
R01 · FY2003 · DA
SUBCLINICAL ATHEROSCLEROSIS IN HIV+ BLACK COCAINE USERS$490,500
R01 · FY2002 · DA
HIV, Cocaine &Regional Left Ventricular Dysfunction$414,623
R01 · FY2002 · DA
CORE--DATA MANAGEMENT AND STATISTICS$124,146
P01 · FY2002 · MH
CORE--DATA MANAGEMENT AND STATISTICS$124,146
P01 · FY2002 · MH
SUBCLINICAL ATHEROSCLEROSIS IN HIV+ BLACK COCAINE USERS$101,779
R01 · FY2002 · DA
SUBCLINICAL ATHEROSCLEROSIS IN HIV+ BLACK COCAINE USERS$490,500
R01 · FY2001 · DA
CORE--DATA MANAGEMENT AND STATISTICS$124,146
P01 · FY2001 · MH
SUBCLINICAL ATHEROSCLEROSIS IN HIV+ BLACK COCAINE USERS$409,792
R01 · FY2000 · DA
CORE--DATA MANAGEMENT AND STATISTICS$272,084
P01 · FY2000 · MH
SUBCLINICAL ATHEROSCLEROSIS IN HIV+ BLACK COCAINE USERS$81,958
R01 · FY2000 · DA